biomarker-guided hf therapy: is it cost-effective?
DESCRIPTION
Biomarker-Guided HF Therapy: Is It Cost-Effective?. Age-Adjusted Hospitalization Rates for Heart Failure. Cost* of Heart Failure to Society. Diagnostic Uncertainty Is Associated With Poor Prognosis in Acute Dyspnea. - PowerPoint PPT PresentationTRANSCRIPT